Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality

被引：9
|
作者：
Feher, Michael [1 ]
Joy, Mark [1 ]
Munro, Neil [2 ]
Hinton, William [1 ]
Williams, John [1 ]
de Lusignan, Simon [1 ]
机构：
[1] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Clin Informat & Hlth Outcomes Res Grp, Oxford, England
[2] Univ Surrey, Dept Clin & Expt Med, Guildford, Surrey, England
来源：
ATHEROSCLEROSIS | 2021年 / 339卷
关键词：
Fenofibrate; COVID-19;
D O I：
10.1016/j.atherosclerosis.2021.11.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [21] Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study
    Wang, Wenjuan
    Snell, Luke B.
    Ferrari, Davide
    Goodman, Anna L.
    Price, Nicholas M.
    Wolfe, Charles D.
    Curcin, Vasa
    Edgeworth, Jonathan D.
    Wang, Yanzhong
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [22] Real-World Safety and Effectiveness of Remdesivir and Corticosteroids in Hospitalized Patients with COVID-19
    Caffrey, Aisling R.
    Liao, J. Xin
    Lopes, Vrishali V.
    LaPlante, Kerry L.
    Appaneal, Haley J.
    COVID, 2023, 3 (02): : 198 - 217
  • [23] Why COVID-19 modelling of progression and prevention fails to translate to the real-world
    Heneghan, Carl J.
    Jefferson, Tom
    ADVANCES IN BIOLOGICAL REGULATION, 2022, 86
  • [24] A real-world intelligent system for the diagnosis and triage of COVID-19 in the emergency department
    Leidinger, Miguel Lastra
    Royon, Francisco Aragon
    Etxeberria, Oier
    Balderas, Luis
    Ramos-Bossini, Antonio Jesus Lainez
    Milena, Genaro Lopez
    Alfonso, Liz
    Moreno, Rosario
    Arauzo, Antonio
    Benitez, Jose M.
    SIGNA VITAE, 2023, 19 (03) : 91 - 102
  • [25] Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study
    Wenjuan Wang
    Luke B Snell
    Davide Ferrari
    Anna L Goodman
    Nicholas M Price
    Charles D Wolfe
    Vasa Curcin
    Jonathan D Edgeworth
    Yanzhong Wang
    BMC Infectious Diseases, 22
  • [26] Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease
    Laura C. Sahyoun
    Jonathan Fetene
    Chandler McMillan
    Petr Protiva
    Badr Al Bawardy
    Jill K. J. Gaidos
    Deborah Proctor
    Digestive Diseases and Sciences, 2024, 69 : 1654 - 1660
  • [27] Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-world setting
    Grimaldi, L.
    Verdoux, M.
    Frank-Soltysiak, M.
    Cohen, A.
    Duclos-Vallee, J. C.
    Corpechot, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 71 - 72
  • [28] COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences
    Hood, Veronica
    Berg, Anne T.
    Knupp, Kelly G.
    Koh, Sookyong
    Laux, Linda
    Meskis, Mary Anne
    Zulfiqar-Ali, Quratulain
    Perry, M. Scott
    Scheffer, Ingrid E.
    Sullivan, Joseph
    Wirrell, Elaine
    Andrade, Danielle M.
    EPILEPSIA, 2022, 63 (07) : 1778 - 1786
  • [29] Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA
    Rich, Carly
    Eriksson, Daniel
    Dolfi, Fabrizio
    Jablonska, Katarzyna
    Dabbous, Firas
    Nazir, Jameel
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 207 (02) : 218 - 226
  • [30] Predictors of Real-World Parents' Acceptance to Vaccinate Their Children Against the COVID-19
    Galanis, Petros
    Vraka, Irene
    Siskou, Olga
    Konstantakopoulou, Olympia
    Katsiroumpa, Aglaia
    Moisoglou, Ioannis
    Kaitelidou, Daphne
    ACTA MEDICA LITUANICA, 2022, 29 (01) : 33 - 43
12345